CRVO CervoMed Inc.

$3.92 +2.08%

Healthcare · Pharmaceutical Preparations

CervoMed Inc. (CRVO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $36 million. Shares last traded at $3.92, 76.3% below their 52-week high. Over the past year the stock is down 45.9%. Net profit margin is -673.2%, below the peer median of -0.1%. Revenue declined 58.9% year over year.

Market Cap

$36M

Shares Out

9.3M

EPS (TTM)

$98810408.16

P/E Ratio

0.00

P/S Ratio

9.06

P/B Ratio

3.42

Dividend / Share

—

Dividend Yield

—

52-Week High

$16.55

52-Week Low

$2.17

Volume

1.5M

Avg Vol (3m)

89,391.048

Performance

+58.06%

+36.82%

-7.55%

-53.33%

YTD

-49.42%

-45.93%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI.

Technicals

RSI (14)

62.50

SMA (50)

$3.50

SMA (200)

$6.04

Price vs SMA50

+11.91%

Price vs SMA200

-35.09%

ATR (14)

$0.87

Financials

Revenue

$4M

Net Income

$-27M

Gross Margin

1.8%

Operating Margin

-706.2%

Net Margin

-673.2%

Return on Equity

-254.1%

Return on Assets

-178.5%

Current Ratio

3.25

Debt / Equity

0.42

Revenue Growth (YoY)

-58.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2024	$-1.22	2024-11-12
Q3 2024	$-2.37	2024-11-12
FY 2022	$2038891.00	2023-03-24
Q3 2023	$-8.25	2023-11-13
FY 2022	$1946859.00	2023-03-24
Q3 2021	$98810420.00	2021-11-10

Full earnings history →

Pharmaceutical Preparations peers

CRVO vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

9.06 / 3.54 med

+156% premium

Net margin vs peers

-673.2% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.